Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tatsuyuki, Inoue"'
Autor:
Hidetoshi Kagawa, Ryutaro Yamanaka, Ai Matsubara, Tatsuyuki Inoue, Reika Hayashi, Natsuki Kubota, Tsutomu Hiromasa
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 15 (2024)
Background: The criteria for remission in both clinical and pathological contexts for lupus nephritis (LN) remain controversial. Objectives: To identify optimal short-term goals (remission criteria) for LN predicting long-term success at 5 years, usi
Externí odkaz:
https://doaj.org/article/6df20133df764673b3ca7c1f1c6987a6
Autor:
Keiko Tanaka, Masashi Kitagawa, Akifumi Onishi, Toshio Yamanari, Ayu Ogawa-Akiyama, Koki Mise, Tatsuyuki Inoue, Hiroshi Morinaga, Haruhito A. Uchida, Hitoshi Sugiyama, Jun Wada
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 2, Pp 284-293 (2017)
Background/Aims: Bleeding is the most common complication after renal biopsy. Although numerous predictors of bleeding have been reported, it remains unclear whether arterial stiffness affects bleeding complications. Method: We performed an observati
Externí odkaz:
https://doaj.org/article/a70602b6136b4c1f81c20a66b3ad4c01
Publikováno v:
Precision Engineering. 75:153-166
Autor:
Yoshia Miyawaki, Takayuki Katsuyama, Ken-Ei Sada, Sumie Hiramatsu, Keiji Ohashi, Michiko Morishita, Eri Katsuyama, Haruki Watanabe, Mariko Takano-Narazaki, Noriko Toyota-Tatebe, Katsue Sunahori-Watanabe, Tomoko Kawabata, Tatsuyuki Inoue, Masaru Kinomura, Hitoshi Sugiyama, Jun Wada
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0178018 (2017)
To evaluate the incidence of GC-DM among patients with immunoglobulin A nephropathy (IgAN) and to confirm the risk factors for the development of GC-DM.The medical records of patients with IgAN newly treated with the protocol of tonsillectomy combine
Externí odkaz:
https://doaj.org/article/20caf781094a4eba96c4efbfb67cf039
Autor:
Masashi Kitagawa, Hitoshi Sugiyama, Hiroshi Morinaga, Tatsuyuki Inoue, Keiichi Takiue, Ayu Ogawa, Toshio Yamanari, Yoko Kikumoto, Haruhito Adam Uchida, Shinji Kitamura, Yohei Maeshima, Kazufumi Nakamura, Hiroshi Ito, Hirofumi Makino
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56695 (2013)
BACKGROUND: Klotho was originally identified in a mutant mouse strain unable to express the gene that consequently showed shortened life spans. In humans, low serum Klotho levels are related to the prevalence of cardiovascular diseases in community-d
Externí odkaz:
https://doaj.org/article/7edd46caa3c44b1ead18318c709af3f9
Autor:
Tatsuyuki Inoue, Hitoshi Sugiyama, Masashi Kitagawa, Keiichi Takiue, Hiroshi Morinaga, Ayu Ogawa, Yoko Kikumoto, Shinji Kitamura, Yohei Maeshima, Hirofumi Makino
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33965 (2012)
The pathogenesis of IgA nephropathy (IgAN) may be associated with the mesangial deposition of aberrantly glycosylated IgA1. To identify mediators affected by aberrantly glycosylated IgA1 in cultured human mesangial cells (HMCs), we generated enzymati
Externí odkaz:
https://doaj.org/article/687be889f0b34afcb4dc422036a6d9e8
Autor:
Ryutaro Yamanaka, Hidetoshi Kagawa, Ken-Ei Sada, Reika Hayashi, Tatsuyuki Inoue, Yoko Tsunashima, Tsutomu Hiromasa
Publikováno v:
Clinical and Experimental Nephrology. 22:1371-1378
Despite the high efficacy of mycophenolate mofetil (MMF)/tacrolimus-based multitarget treatment, risks of infections are a matter of concern. In the present study, we clarified the potential of multitarget therapy using mizoribine opposed to MMF. A t
Autor:
Tatsuyuki Inoue, Hiroshi Morinaga, Ayu Ogawa-Akiyama, Jun Wada, Hitoshi Sugiyama, Keiko Tanaka, Haruhito A. Uchida, Toshio Yamanari, Koki Mise, Masashi Kitagawa, Akifumi Onishi
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 2, Pp 284-293 (2017)
Background/Aims: Bleeding is the most common complication after renal biopsy. Although numerous predictors of bleeding have been reported, it remains unclear whether arterial stiffness affects bleeding complications. Method: We performed an observati
Autor:
Tatsuyuki, Inoue, Kenji, Osafune
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 73